Massachusetts Financial Services’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$221M Buy
1,617,021
+219,506
+16% +$27M 0.07% 256
2026
Q1
$165M Buy
1,397,515
+181,988
+15% +$25.4M 0.06% 280
2025
Q4
$199M Buy
+1,215,527
New +$190M 0.06% 266
2023
Q2
Sell
-267,374
Closed -$45M 867
2023
Q1
$45M Buy
267,374
+2,891
+1% +$516K 0.02% 454
2022
Q4
$44.8M Buy
264,483
+69,933
+36% +$12.7M 0.02% 463
2022
Q3
$36.4M Buy
+194,550
New +$41M 0.01% 496

Other funds holding RGEN

Massachusetts Financial Services's RGEN Position: Q2 2026 in Review

Massachusetts Financial Services increased its Repligen (RGEN) stake by 16% in Q2 2026, buying an estimated $27M and bringing the position to 1,617,021 shares worth $221M. The position accounts for 0.07% of the portfolio, ranked #256.

Massachusetts Financial Services first reported a position in RGEN in Q3 2022 and has held it in 6 quarters since. 480 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

  • Massachusetts Financial Services held 1,617,021 shares of Repligen worth $221M as of Q2 2026.
  • Massachusetts Financial Services bought 219,506 Repligen shares in Q2 2026, an estimated $27M.
  • Repligen made up 0.07% of Massachusetts Financial Services's portfolio in Q2 2026, its #256 holding.
  • Massachusetts Financial Services first reported a position in Repligen in Q3 2022 and has held it in 6 quarters since.
  • 480 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on Massachusetts Financial Services's 13F filing for Q2 2026, filed 3 Aug 2026.